NO973178D0 - Indol-derivater anvendelige ved behandling av osteporose - Google Patents
Indol-derivater anvendelige ved behandling av osteporoseInfo
- Publication number
- NO973178D0 NO973178D0 NO973178A NO973178A NO973178D0 NO 973178 D0 NO973178 D0 NO 973178D0 NO 973178 A NO973178 A NO 973178A NO 973178 A NO973178 A NO 973178A NO 973178 D0 NO973178 D0 NO 973178D0
- Authority
- NO
- Norway
- Prior art keywords
- porosis
- cheese
- treatment
- indole derivatives
- derivatives useful
- Prior art date
Links
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 235000013351 cheese Nutrition 0.000 title 1
- 150000002475 indoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI950030A IT1272878B (it) | 1995-01-10 | 1995-01-10 | Composti indolici |
IT95MI001687 IT1307328B1 (it) | 1995-08-01 | 1995-08-01 | Composti indolici |
PCT/EP1996/000157 WO1996021644A1 (en) | 1995-01-10 | 1996-01-08 | Indole derivatives useful in the treatment of osteoporosis |
Publications (2)
Publication Number | Publication Date |
---|---|
NO973178D0 true NO973178D0 (no) | 1997-07-09 |
NO973178L NO973178L (no) | 1997-09-09 |
Family
ID=26331230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO973178A NO973178L (no) | 1995-01-10 | 1997-07-09 | Indol-derivater anvendelige ved behandling av osteoporose |
Country Status (19)
Country | Link |
---|---|
US (1) | US5981525A (no) |
EP (1) | EP0802902A1 (no) |
JP (1) | JPH10512251A (no) |
KR (1) | KR19980701330A (no) |
AP (1) | AP648A (no) |
AU (1) | AU4536096A (no) |
BG (1) | BG101769A (no) |
BR (1) | BR9606743A (no) |
CA (1) | CA2209936A1 (no) |
CZ (1) | CZ217697A3 (no) |
EA (1) | EA199700098A1 (no) |
FI (1) | FI972919A (no) |
HU (1) | HUP9901096A3 (no) |
NO (1) | NO973178L (no) |
OA (1) | OA10611A (no) |
PL (1) | PL321263A1 (no) |
SK (1) | SK93297A3 (no) |
TR (1) | TR199700625T1 (no) |
WO (1) | WO1996021644A1 (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5977125A (en) * | 1994-10-31 | 1999-11-02 | Eisai Co., Ltd. | Mono-or polyenic carboxylic acid derivatives |
GB9614347D0 (en) * | 1996-07-09 | 1996-09-04 | Smithkline Beecham Spa | Novel compounds |
PL330994A1 (en) * | 1996-07-09 | 1999-06-21 | Smithkline Beecham Spa | Indolic derivatives for use in treating osteoporosis |
GB9614366D0 (en) * | 1996-07-09 | 1996-09-04 | Smithkline Beecham Spa | Novel compounds |
GB9703109D0 (en) * | 1997-02-14 | 1997-04-02 | Smith & Nephew | Compositions |
ATE231128T1 (de) | 1997-02-21 | 2003-02-15 | Takeda Chemical Industries Ltd | Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung |
US6054587A (en) * | 1997-03-07 | 2000-04-25 | Metabasis Therapeutics, Inc. | Indole and azaindole inhibitors of fructose-1,6-bisphosphatase |
US6284748B1 (en) | 1997-03-07 | 2001-09-04 | Metabasis Therapeutics, Inc. | Purine inhibitors of fructose 1,6-bisphosphatase |
BR9814403A (pt) * | 1997-12-24 | 2000-10-10 | Smithkline Beecham Lab | "derivados do indol úteis para o tratamento, entre outros, de osteoporose" |
US6506758B2 (en) | 1997-12-24 | 2003-01-14 | Smithkline Beecham Laboratoires Pharmceutiques | Indole derivatives useful A.O. for the treatment of osteoporosis |
US6861448B2 (en) * | 1998-01-14 | 2005-03-01 | Virtual Drug Development, Inc. | NAD synthetase inhibitors and uses thereof |
US6673827B1 (en) | 1999-06-29 | 2004-01-06 | The Uab Research Foundation | Methods of treating fungal infections with inhibitors of NAD synthetase enzyme |
DE69918799D1 (de) | 1998-01-14 | 2004-08-26 | Uab Res Foundation Birmingham | Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren |
GB9914371D0 (en) * | 1999-06-18 | 1999-08-18 | Smithkline Beecham Plc | Novel compounds |
SE9903760D0 (sv) | 1999-10-18 | 1999-10-18 | Astra Ab | New compounds |
SE9904176D0 (sv) * | 1999-11-18 | 1999-11-18 | Astra Ab | New use |
AR035857A1 (es) | 2001-04-11 | 2004-07-21 | Novirio Pharmaceuticals Ltd | Fenilindoles; sus composiciones farmaceuticas y sus usos |
US20040259909A1 (en) * | 2001-10-16 | 2004-12-23 | Mccarthy Dennis | Treatment of fibromyalgia syndrome |
JP2006500355A (ja) * | 2002-08-07 | 2006-01-05 | イデニクス(ケイマン)リミテツド | Hiv治療用の置換フェニルインドール類 |
ITMI20040875A1 (it) * | 2004-04-30 | 2004-07-30 | Ist Naz Stud Cura Dei Tumori | Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali |
MX2007003040A (es) | 2004-09-17 | 2007-08-02 | Idenix Pharmaceuticals Inc | Fosfoindoles como inhibidores de vih. |
CA2599890C (en) * | 2005-03-03 | 2011-05-03 | H. Lundbeck A/S | Substituted pyridine derivatives |
AU2007305447A1 (en) | 2006-09-29 | 2008-04-10 | Idenix Pharmaceuticals, Inc | Enantiomerically pure phosphoindoles as HIV inhibitors |
LU91725B1 (en) | 2010-09-02 | 2012-03-05 | Ct De Rech Public De La Sante | Novel uses of V-ATPASE inhibitors |
US9115128B2 (en) * | 2013-06-06 | 2015-08-25 | Anthem Biosciences Pvt. Ltd. | Compounds of 3-(5-substituted Oxy-2, 4-dinitrophenyl)-2-oxo-propionic acid ester, synthesis and applications thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69102919T2 (de) * | 1990-03-20 | 1994-12-15 | Sharp Kk | Verfahren zur Montage von einer Halbleiteranordnung. |
CA2038925A1 (en) * | 1990-03-26 | 1991-09-27 | Takashi Sohda | Indole derivatives, their production and use |
US5312928A (en) * | 1991-02-11 | 1994-05-17 | Cambridge Neuroscience | Calcium channel antagonists and methodology for their identification |
-
1996
- 1996-01-08 EP EP96901275A patent/EP0802902A1/en not_active Withdrawn
- 1996-01-08 AU AU45360/96A patent/AU4536096A/en not_active Abandoned
- 1996-01-08 BR BR9606743A patent/BR9606743A/pt unknown
- 1996-01-08 HU HU9901096A patent/HUP9901096A3/hu unknown
- 1996-01-08 CA CA002209936A patent/CA2209936A1/en not_active Abandoned
- 1996-01-08 WO PCT/EP1996/000157 patent/WO1996021644A1/en not_active Application Discontinuation
- 1996-01-08 KR KR1019970704719A patent/KR19980701330A/ko not_active Application Discontinuation
- 1996-01-08 US US08/860,760 patent/US5981525A/en not_active Expired - Fee Related
- 1996-01-08 SK SK932-97A patent/SK93297A3/sk unknown
- 1996-01-08 TR TR97/00625T patent/TR199700625T1/xx unknown
- 1996-01-08 AP APAP/P/1997/001029A patent/AP648A/en active
- 1996-01-08 PL PL96321263A patent/PL321263A1/xx unknown
- 1996-01-08 CZ CZ972176A patent/CZ217697A3/cs unknown
- 1996-01-08 JP JP8521450A patent/JPH10512251A/ja active Pending
-
1997
- 1997-07-07 BG BG101769A patent/BG101769A/xx unknown
- 1997-07-09 NO NO973178A patent/NO973178L/no unknown
- 1997-07-09 FI FI972919A patent/FI972919A/fi unknown
- 1997-07-09 OA OA70046A patent/OA10611A/en unknown
- 1997-08-08 EA EA199700098A patent/EA199700098A1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
CZ217697A3 (cs) | 1998-03-18 |
TR199700625T1 (xx) | 1998-02-21 |
CA2209936A1 (en) | 1996-07-18 |
BR9606743A (pt) | 1997-12-30 |
AP648A (en) | 1998-05-25 |
KR19980701330A (ko) | 1998-05-15 |
PL321263A1 (en) | 1997-11-24 |
US5981525A (en) | 1999-11-09 |
EP0802902A1 (en) | 1997-10-29 |
EA199700098A1 (ru) | 1997-12-30 |
NO973178L (no) | 1997-09-09 |
MX9705243A (es) | 1997-10-31 |
JPH10512251A (ja) | 1998-11-24 |
HUP9901096A3 (en) | 2000-12-28 |
SK93297A3 (en) | 1998-02-04 |
BG101769A (en) | 1998-04-30 |
AP9701029A0 (en) | 1997-07-31 |
FI972919A0 (fi) | 1997-07-09 |
AU4536096A (en) | 1996-07-31 |
OA10611A (en) | 2002-09-03 |
HUP9901096A2 (hu) | 1999-07-28 |
WO1996021644A1 (en) | 1996-07-18 |
FI972919A (fi) | 1997-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO973178D0 (no) | Indol-derivater anvendelige ved behandling av osteporose | |
NO962179L (no) | Fremgangsmåte for fremstilling av metallocen og anvendelse derav | |
NO986052D0 (no) | Antikonvulsive derivater for behandling av fedme | |
DE69612279D1 (de) | Behandlung schwerer aromaten | |
NO991955L (no) | FremgangsmÕte for behandling av hydrokarboner | |
FI964874A (fi) | Vihannesten käsittely | |
NO961006D0 (no) | Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene | |
NO963322D0 (no) | Fremgangsmåte for behandling av abstinens ved stoffmisbruk | |
NO20012963D0 (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
BR9609445A (pt) | Derivados de azetidinona no tratamento de aterosclerose | |
NO982237L (no) | FremgangsmÕte for fremstilling av fenylimidazolidinderivater | |
NO983068D0 (no) | FremgangsmÕte for fremstilling av bis-syklopentadienyl-dien komplekser | |
NO991621L (no) | Antikonvulsantderivater anvendelige ved behandling av neuropatisk smerte | |
NO964551D0 (no) | Imidazolderivater og fremgangsmåte for fremstilling av slike | |
NO304110B1 (no) | FremgangsmÕte for fremstilling av glutardialdehyd | |
NO980316D0 (no) | Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam | |
NO982503D0 (no) | FremgangsmÕte ved fremstilling av dioksoazabicykloheksaner | |
NO981499D0 (no) | Fremgangsmåte for fremstilling av titandioksyd | |
NO986053L (no) | Anticonvulsivt virkende derivater for anvendelse ved behandling av psoriasis | |
FI951047A (fi) | Menetelmä indolijohdannaisten valmistamiseksi | |
NO972129D0 (no) | Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater | |
NO942381L (no) | Fremgangsmåte for fremstilling av indoler | |
EP0714659A3 (en) | Indole derivatives in the treatment of emesis | |
NO953459D0 (no) | Fremgangsmåte ved fremstilling av cykloheptimidazolderivater | |
NO964519D0 (no) | Fremgangsmåte for fremstilling av chitosanalkylderivater |